Abstract | INTRODUCTION: MATERIALS AND METHODS: RESULTS: NSS improved significantly at 24 hour (P<0.001) and 48 hour (P<0.001) only in the rats treated with oxaloacetate. Blood glutamate decreased significantly in the oxaloacetate-treated group at 90 minute (at the conclusion of oxaloacetate administration) (P<0.00001), but not in the control, maleate or oxaloacetate+maleate groups. A strong correlation r2=0.86 was found to exist between the percent decrease in blood glutamate levels and percent improvement in NSS. DISCUSSION: The results of this study demonstrate that the primary mechanism by which oxaloacetate provides neuroprotective activity after CHI is related to its blood glutamate scavenging activity. Management of blood glutamate concentration may have important implications in the treatment of acute brain conditions, including CHI and stroke.
|
Authors | Alexander Zlotnik, Shaun E Gruenbaum, Alan A Artru, Irene Rozet, Michael Dubilet, Sergey Tkachov, Evgeny Brotfain, Yael Klin, Yoram Shapira, Vivian I Teichberg |
Journal | Journal of neurosurgical anesthesiology
(J Neurosurg Anesthesiol)
Vol. 21
Issue 3
Pg. 235-41
(Jul 2009)
ISSN: 1537-1921 [Electronic] United States |
PMID | 19543002
(Publication Type: Journal Article)
|
Chemical References |
- Enzyme Inhibitors
- Maleates
- Neuroprotective Agents
- Oxaloacetic Acid
- Glutamic Acid
- maleic acid
- Aspartate Aminotransferase, Cytoplasmic
|
Topics |
- Animals
- Aspartate Aminotransferase, Cytoplasmic
(antagonists & inhibitors, metabolism)
- Behavior, Animal
(drug effects)
- Blood Gas Analysis
- Enzyme Inhibitors
(pharmacology)
- Glutamic Acid
(blood)
- Head Injuries, Closed
(drug therapy, psychology)
- Male
- Maleates
(pharmacology)
- Neuroprotective Agents
- Oxaloacetic Acid
(pharmacology)
- Psychomotor Performance
(drug effects)
- Rats
- Rats, Sprague-Dawley
|